ARCUS BIOSCIENCES AND SUMMIT THERAPEUTICS ENTER INTO CLINICAL TRIAL COLLABORATION TO EVALUATE CASDATIFAN COMBINED WITH IVONESCIMAB IN KIDNEY CANCER

Reuters · 2d ago

Please log in to view news